Ignite Creation Date:
2025-12-25 @ 2:37 AM
Ignite Modification Date:
2026-02-27 @ 5:10 PM
Study NCT ID:
NCT02238834
Status:
COMPLETED
Last Update Posted:
2022-08-08
First Post:
2014-09-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Safety, Tolerability and Pharmacokinetics (PK) Study of FP-025 in Healthy Volunteers
Sponsor:
Foresee Pharmaceuticals Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-06
Start Date Type:
ACTUAL
Primary Completion Date:
2018-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-12
Completion Date Type:
ACTUAL
First Submit Date:
2014-09-05
First Submit QC Date:
None
Study First Post Date:
2014-09-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-04
Last Update Post Date:
2022-08-08
Last Update Post Date Type:
ACTUAL